Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome
coronavirus 2 is a global pandemic that has resulted in over 1.5 million confirmed cases and …

Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …

There are many uncertainties on the future management of the coronavirus disease 19
(COVID-19) in Africa. By July 2021, Africa had lagged behind the rest of the world in Covid …

Accurate and rapid diagnostic tests are critical for achieving control of coronavirus disease
2019 (covid-19), a pandemic illness caused by severe acute respiratory syndrome …

The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the
related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the …

The potential role for serological tests in the current COVID-19 pandemic has generated
very considerable recent interest across many sectors worldwide, inter alia pathologists …

Countries globally are affected by the COVID-19 pandemic, with nearly two million cases
and 120 000 deaths occurring within 4 months of the discovery of the severe acute …

Coronavirus disease 2019 (COVID-19) caused a fatal pandemic worldwide. This review
aims to discuss laboratory, molecular, and serological methods and their advantages and …

Since the beginning of the New Year 2020, countries around the world are stumbling due to
the coronavirus disease (COVID-19) pandemic. Better approaches of diagnostics and …

Background Molecular detection of SARS-CoV-2 in respiratory samples is the gold standard
for COVID-19 diagnosis but it has a long turnaround time and struggles to detect low viral …